Fetal Fentanyl Syndrome: Unveiling a New Syndrome Linked to Fentanyl Use During Pregnancy
Dr. Karen Gripp, MD, Chief of the Division of Medical Genetics at Nemours Children’s Health in Wilmington, has been at…
Global Precision Medicine Market Report
September 22, 2017
“Advancements in genomics and big data analytics are driving growth in the precision medicine market: Next-generation sequencing and genomic profiling technologies have advanced significantly in recent years, enabling better detection and understanding of diseases at the molecular level.”
The precision medicine market is projected to reach USD 92.31 billion by 2024, driven by innovations like FDNA’s Face2Gene platform. Face2Gene leverages artificial intelligence and deep learning to analyze facial features, aiding in the accurate expedited diagnosis of genetic disorders. This technology exemplifies the growing impact of AI in precision medicine, enabling personalized treatment plans based on individual genetic profiles. The market expansion reflects an increasing demand for tailored healthcare solutions and advanced decision support tools, underscoring the critical role of platforms like Face2Gene in revolutionizing patient care and improving health outcomes globally.
Related articles
Continue reading
Interview with Dr. Giulia Pascolini: Unravelling the Genetic Underpinnings of Dermatological Anomalies
Dr Giulia Pascolini, an esteemed Italian M.D. and Ph.D., is currently responsible for the Genetic Counselling Service of the Istituto…
Spanish Coffin Siris Syndrome Association: Fighting for Health and Recognition
Founded in 2017, the Spanish Coffin Siris Syndrome Association is an organization dedicated to supporting families affected by this rare…